KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Demonstrated Clinically …,

KEYNOTE-524/Study 116 (ClinicalTrials.gov, NCT03006926 ) is a Phase 1b, open-label, single-arm trial evaluating the KEYTRUDA plus LENVIMA …, KEYNOTE-524/Study 116 (ClinicalTrials.gov, NCT03006926 ) is a Phase 1b, open-label, single-arm trial evaluating the KEYTRUDA plus LENVIMA …, Read More

Scroll to Top